Sandbox: Difference between revisions
Leroux6000 (talk | contribs) No edit summary |
|||
| Line 66: | Line 66: | ||
| Hospitalization, immediate chelation, case management | | Hospitalization, immediate chelation, case management | ||
|} | |} | ||
[https://curbsidehealth.com/pathways/275/edit?uuid=79a30f97-97aa-5daa-847f-95cd64f7e8ea Test MIS-C pathway] | |||
Revision as of 01:13, 19 August 2022
| |||||
Clinical Features
- Absence of GI symptoms within 6hr of ingestion excludes significant iron ingestion (exception: enteric coated tablets)
- Significant iron toxicity can result in a severe lactic acidosis from hypoperfusion due to volume loss, vasodilation and negative inotropin effects.
| Staging | Clinical Effect | Time Frame |
|---|---|---|
| Stage 1 | GI irritation: nausea and vomiting, abdominal pain, diarrhea | 30 mins-6 hours |
| Stage 2: Latent | Reduced GI symptoms | 6-24 hours |
| Stage 3: Shock and metabolic acidosis | Metabolic acidosis, lactic acidosis, dehydration | 6-72 hours |
| Stage 4: Hepatotoxicity/ Hepatic necrosis | Hepatic failure | 12-96 hours |
| Stage 5: Bowel obstruction | GI mucosa healing leads to scarring | 2-8 weeks |
- Stage I: GI toxicity: nausea, vomiting, diarrhea, GI bleeding from local corrosive effects of iron on the gastric and intestinal mucosa
- Stage II: Quiescent phase with resolution of GI symptoms and apparent clinical improvement
- controversy between toxicologists whether this stage exists in significant poisonings
- Stage III: Systemic toxicity: shock and hypoperfusion
- Primarily hypovolemic shock and acidosis, myocardial dysfunction also contributes
- GI fluid losses, increase capillary permeability, decreased venous tone
- Severe anion gap acidosis
- Free radical damage to mitochondria disrupt oxidative phosphorylation which leads to lactic acidosis
- Hepatotoxicity from iron delivery via portal blood flow
- Stage IV: Clinical recovery, resolution of shock and acidosis usually by days 3-4
- Stage V: Late onset of gastric and pyloric strictures (2-8 week later) [1]
| Blood lead level (μg/dL) | Treatment |
|---|---|
| 10–14 | Education, repeat screening |
| 15–19 | Repeat screening, case management to abate sources |
| 20–44 | Medical evaluation, case management |
| 45–69 | Medical evaluation, chelation, case management |
| >69 | Hospitalization, immediate chelation, case management |
- ↑ Fine, J. Iron Poisoning. Curr Probl Pediatr, Vol 30, Iss 3, p 71-90, March 2000
- ↑ Kosnett (2006) p. 242
